Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization
Mucins are essential for airway defense against bacteria. We hypothesized that abnormal secreted airway mucin levels would be associated with bacterial colonization in patients with severe chronic obstructive pulmonary disease (COPD) Objectives: To investigate the relationship between mucin levels a...
Gespeichert in:
Veröffentlicht in: | Annals of the American Thoracic Society 2016-05, Vol.13 (5), p.636-642 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 642 |
---|---|
container_issue | 5 |
container_start_page | 636 |
container_title | Annals of the American Thoracic Society |
container_volume | 13 |
creator | Sibila, Oriol Garcia-Bellmunt, Laia Giner, Jordi Rodrigo-Troyano, Ana Suarez-Cuartin, Guillermo Torrego, Alfons Castillo, Diego Solanes, Ingrid Mateus, Eder F Vidal, Silvia Sanchez-Reus, Ferran Sala, Ernest Cosio, Borja G Restrepo, Marcos I Anzueto, Antonio Chalmers, James D Plaza, Vicente |
description | Mucins are essential for airway defense against bacteria. We hypothesized that abnormal secreted airway mucin levels would be associated with bacterial colonization in patients with severe chronic obstructive pulmonary disease (COPD) Objectives: To investigate the relationship between mucin levels and the presence of potentially pathogenic micro-organisms in the airways of stable patients with severe COPD Methods: Clinically stable patients with severe COPD were examined prospectively. All patients underwent a computerized tomography scan, lung function tests, induced sputum collection, and bronchoscopy with bronchoalveolar lavage (BAL) and protected specimen brush. Patients with bronchiectasis were excluded. Secreted mucins (MUC2, MUC5AC, and MUC5B) and inflammatory markers were assessed in BAL and sputum by ELISA.
We enrolled 45 patients, with mean age (±SD) of 67 (±8) years and mean FEV1 of 41 (±10) % predicted. A total of 31% (n = 14) of patients had potentially pathogenic micro-organisms in quantitative bacterial cultures of samples obtained by protected specimen brush. Patients with COPD with positive cultures had lower levels of MUC2 both in BAL (P = 0.02) and in sputum (P = 0.01). No differences in MUC5B or MUC5AC levels were observed among the groups. Lower MUC2 levels were correlated with lower FEV1 (r = 0.32, P = 0.04) and higher sputum IL-6 (r = -0.40, P = 0.01).
Airway MUC2 levels are decreased in patients with severe COPD colonized by potentially pathogenic micro-organisms. These findings may indicate one of the mechanisms underlying airway colonization in patients with severe COPD. Clinical trial registered with www.clinicaltrials.gov (NCT01976117). |
doi_str_mv | 10.1513/AnnalsATS.201512-797OC |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6137898</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1787476722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-649d2e18be0b36cc3108843e034d9ff56e86d7a7f241df30137b2b6b09bae01c3</originalsourceid><addsrcrecordid>eNpdkUtP3DAUha2qVUGUv4Assekm1I_Ej02laegDiWqQgLXlODeMUcamdjKI_vp6GDpq8cbW9TlH9-hD6ISSM9pQ_mkRgh3z4ub6jJEyYJXUctm-QYeMs6YSgtG3z29dCc35ATrO-Z6UoxqqpH6PDphQitWEHaJ54dOjfcI_Z-cDZvgi43NwCWyGHpfJlZ08hCnjRz-t8DVsIAFuVykG7_Cyy1Oa3eQ3gK_mcR2DTU_43Oetfef4Yt0EydsRt3Espt8lL4YP6N1QGsDxy32Ebr99vWl_VJfL7xft4rJydc2mStS6Z0BVB6TjwjlOiVI1B8LrXg9DI0CJXlo5sJr2AyeUy451oiO6s0Co40fo8y73Ye7W0LvSJNnRPCS_LpuaaL35_yf4lbmLGyNKlNKqBHx8CUjx1wx5MmufHYyjDRDnbKhUspZCMlakp6-k93FOW1BblW641pwUldipXIo5Jxj2y1BitnDNHq7ZwTXPcIvx5N8qe9tflPwP7qej5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1789539930</pqid></control><display><type>article</type><title>Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Sibila, Oriol ; Garcia-Bellmunt, Laia ; Giner, Jordi ; Rodrigo-Troyano, Ana ; Suarez-Cuartin, Guillermo ; Torrego, Alfons ; Castillo, Diego ; Solanes, Ingrid ; Mateus, Eder F ; Vidal, Silvia ; Sanchez-Reus, Ferran ; Sala, Ernest ; Cosio, Borja G ; Restrepo, Marcos I ; Anzueto, Antonio ; Chalmers, James D ; Plaza, Vicente</creator><creatorcontrib>Sibila, Oriol ; Garcia-Bellmunt, Laia ; Giner, Jordi ; Rodrigo-Troyano, Ana ; Suarez-Cuartin, Guillermo ; Torrego, Alfons ; Castillo, Diego ; Solanes, Ingrid ; Mateus, Eder F ; Vidal, Silvia ; Sanchez-Reus, Ferran ; Sala, Ernest ; Cosio, Borja G ; Restrepo, Marcos I ; Anzueto, Antonio ; Chalmers, James D ; Plaza, Vicente</creatorcontrib><description>Mucins are essential for airway defense against bacteria. We hypothesized that abnormal secreted airway mucin levels would be associated with bacterial colonization in patients with severe chronic obstructive pulmonary disease (COPD) Objectives: To investigate the relationship between mucin levels and the presence of potentially pathogenic micro-organisms in the airways of stable patients with severe COPD Methods: Clinically stable patients with severe COPD were examined prospectively. All patients underwent a computerized tomography scan, lung function tests, induced sputum collection, and bronchoscopy with bronchoalveolar lavage (BAL) and protected specimen brush. Patients with bronchiectasis were excluded. Secreted mucins (MUC2, MUC5AC, and MUC5B) and inflammatory markers were assessed in BAL and sputum by ELISA.
We enrolled 45 patients, with mean age (±SD) of 67 (±8) years and mean FEV1 of 41 (±10) % predicted. A total of 31% (n = 14) of patients had potentially pathogenic micro-organisms in quantitative bacterial cultures of samples obtained by protected specimen brush. Patients with COPD with positive cultures had lower levels of MUC2 both in BAL (P = 0.02) and in sputum (P = 0.01). No differences in MUC5B or MUC5AC levels were observed among the groups. Lower MUC2 levels were correlated with lower FEV1 (r = 0.32, P = 0.04) and higher sputum IL-6 (r = -0.40, P = 0.01).
Airway MUC2 levels are decreased in patients with severe COPD colonized by potentially pathogenic micro-organisms. These findings may indicate one of the mechanisms underlying airway colonization in patients with severe COPD. Clinical trial registered with www.clinicaltrials.gov (NCT01976117).</description><identifier>ISSN: 2329-6933</identifier><identifier>EISSN: 2325-6621</identifier><identifier>DOI: 10.1513/AnnalsATS.201512-797OC</identifier><identifier>PMID: 26882402</identifier><language>eng</language><publisher>United States: American Thoracic Society</publisher><subject>Aged ; Biomarkers - analysis ; Bronchoalveolar Lavage Fluid - microbiology ; Bronchoscopy ; Cross-Sectional Studies ; Female ; Humans ; Interleukin-6 - analysis ; Linear Models ; Lung - microbiology ; Lung - physiopathology ; Male ; Middle Aged ; Mucin-2 - analysis ; Original Research ; Prospective Studies ; Pulmonary Disease, Chronic Obstructive - microbiology ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Spain ; Sputum - microbiology ; Vital Capacity</subject><ispartof>Annals of the American Thoracic Society, 2016-05, Vol.13 (5), p.636-642</ispartof><rights>Copyright American Thoracic Society May 2016</rights><rights>Copyright © 2016 by the American Thoracic Society 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-649d2e18be0b36cc3108843e034d9ff56e86d7a7f241df30137b2b6b09bae01c3</citedby><cites>FETCH-LOGICAL-c442t-649d2e18be0b36cc3108843e034d9ff56e86d7a7f241df30137b2b6b09bae01c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26882402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sibila, Oriol</creatorcontrib><creatorcontrib>Garcia-Bellmunt, Laia</creatorcontrib><creatorcontrib>Giner, Jordi</creatorcontrib><creatorcontrib>Rodrigo-Troyano, Ana</creatorcontrib><creatorcontrib>Suarez-Cuartin, Guillermo</creatorcontrib><creatorcontrib>Torrego, Alfons</creatorcontrib><creatorcontrib>Castillo, Diego</creatorcontrib><creatorcontrib>Solanes, Ingrid</creatorcontrib><creatorcontrib>Mateus, Eder F</creatorcontrib><creatorcontrib>Vidal, Silvia</creatorcontrib><creatorcontrib>Sanchez-Reus, Ferran</creatorcontrib><creatorcontrib>Sala, Ernest</creatorcontrib><creatorcontrib>Cosio, Borja G</creatorcontrib><creatorcontrib>Restrepo, Marcos I</creatorcontrib><creatorcontrib>Anzueto, Antonio</creatorcontrib><creatorcontrib>Chalmers, James D</creatorcontrib><creatorcontrib>Plaza, Vicente</creatorcontrib><title>Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization</title><title>Annals of the American Thoracic Society</title><addtitle>Ann Am Thorac Soc</addtitle><description>Mucins are essential for airway defense against bacteria. We hypothesized that abnormal secreted airway mucin levels would be associated with bacterial colonization in patients with severe chronic obstructive pulmonary disease (COPD) Objectives: To investigate the relationship between mucin levels and the presence of potentially pathogenic micro-organisms in the airways of stable patients with severe COPD Methods: Clinically stable patients with severe COPD were examined prospectively. All patients underwent a computerized tomography scan, lung function tests, induced sputum collection, and bronchoscopy with bronchoalveolar lavage (BAL) and protected specimen brush. Patients with bronchiectasis were excluded. Secreted mucins (MUC2, MUC5AC, and MUC5B) and inflammatory markers were assessed in BAL and sputum by ELISA.
We enrolled 45 patients, with mean age (±SD) of 67 (±8) years and mean FEV1 of 41 (±10) % predicted. A total of 31% (n = 14) of patients had potentially pathogenic micro-organisms in quantitative bacterial cultures of samples obtained by protected specimen brush. Patients with COPD with positive cultures had lower levels of MUC2 both in BAL (P = 0.02) and in sputum (P = 0.01). No differences in MUC5B or MUC5AC levels were observed among the groups. Lower MUC2 levels were correlated with lower FEV1 (r = 0.32, P = 0.04) and higher sputum IL-6 (r = -0.40, P = 0.01).
Airway MUC2 levels are decreased in patients with severe COPD colonized by potentially pathogenic micro-organisms. These findings may indicate one of the mechanisms underlying airway colonization in patients with severe COPD. Clinical trial registered with www.clinicaltrials.gov (NCT01976117).</description><subject>Aged</subject><subject>Biomarkers - analysis</subject><subject>Bronchoalveolar Lavage Fluid - microbiology</subject><subject>Bronchoscopy</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Interleukin-6 - analysis</subject><subject>Linear Models</subject><subject>Lung - microbiology</subject><subject>Lung - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mucin-2 - analysis</subject><subject>Original Research</subject><subject>Prospective Studies</subject><subject>Pulmonary Disease, Chronic Obstructive - microbiology</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Spain</subject><subject>Sputum - microbiology</subject><subject>Vital Capacity</subject><issn>2329-6933</issn><issn>2325-6621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkUtP3DAUha2qVUGUv4Assekm1I_Ej02laegDiWqQgLXlODeMUcamdjKI_vp6GDpq8cbW9TlH9-hD6ISSM9pQ_mkRgh3z4ub6jJEyYJXUctm-QYeMs6YSgtG3z29dCc35ATrO-Z6UoxqqpH6PDphQitWEHaJ54dOjfcI_Z-cDZvgi43NwCWyGHpfJlZ08hCnjRz-t8DVsIAFuVykG7_Cyy1Oa3eQ3gK_mcR2DTU_43Oetfef4Yt0EydsRt3Espt8lL4YP6N1QGsDxy32Ebr99vWl_VJfL7xft4rJydc2mStS6Z0BVB6TjwjlOiVI1B8LrXg9DI0CJXlo5sJr2AyeUy451oiO6s0Co40fo8y73Ye7W0LvSJNnRPCS_LpuaaL35_yf4lbmLGyNKlNKqBHx8CUjx1wx5MmufHYyjDRDnbKhUspZCMlakp6-k93FOW1BblW641pwUldipXIo5Jxj2y1BitnDNHq7ZwTXPcIvx5N8qe9tflPwP7qej5g</recordid><startdate>201605</startdate><enddate>201605</enddate><creator>Sibila, Oriol</creator><creator>Garcia-Bellmunt, Laia</creator><creator>Giner, Jordi</creator><creator>Rodrigo-Troyano, Ana</creator><creator>Suarez-Cuartin, Guillermo</creator><creator>Torrego, Alfons</creator><creator>Castillo, Diego</creator><creator>Solanes, Ingrid</creator><creator>Mateus, Eder F</creator><creator>Vidal, Silvia</creator><creator>Sanchez-Reus, Ferran</creator><creator>Sala, Ernest</creator><creator>Cosio, Borja G</creator><creator>Restrepo, Marcos I</creator><creator>Anzueto, Antonio</creator><creator>Chalmers, James D</creator><creator>Plaza, Vicente</creator><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201605</creationdate><title>Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization</title><author>Sibila, Oriol ; Garcia-Bellmunt, Laia ; Giner, Jordi ; Rodrigo-Troyano, Ana ; Suarez-Cuartin, Guillermo ; Torrego, Alfons ; Castillo, Diego ; Solanes, Ingrid ; Mateus, Eder F ; Vidal, Silvia ; Sanchez-Reus, Ferran ; Sala, Ernest ; Cosio, Borja G ; Restrepo, Marcos I ; Anzueto, Antonio ; Chalmers, James D ; Plaza, Vicente</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-649d2e18be0b36cc3108843e034d9ff56e86d7a7f241df30137b2b6b09bae01c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Biomarkers - analysis</topic><topic>Bronchoalveolar Lavage Fluid - microbiology</topic><topic>Bronchoscopy</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Interleukin-6 - analysis</topic><topic>Linear Models</topic><topic>Lung - microbiology</topic><topic>Lung - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mucin-2 - analysis</topic><topic>Original Research</topic><topic>Prospective Studies</topic><topic>Pulmonary Disease, Chronic Obstructive - microbiology</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Spain</topic><topic>Sputum - microbiology</topic><topic>Vital Capacity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sibila, Oriol</creatorcontrib><creatorcontrib>Garcia-Bellmunt, Laia</creatorcontrib><creatorcontrib>Giner, Jordi</creatorcontrib><creatorcontrib>Rodrigo-Troyano, Ana</creatorcontrib><creatorcontrib>Suarez-Cuartin, Guillermo</creatorcontrib><creatorcontrib>Torrego, Alfons</creatorcontrib><creatorcontrib>Castillo, Diego</creatorcontrib><creatorcontrib>Solanes, Ingrid</creatorcontrib><creatorcontrib>Mateus, Eder F</creatorcontrib><creatorcontrib>Vidal, Silvia</creatorcontrib><creatorcontrib>Sanchez-Reus, Ferran</creatorcontrib><creatorcontrib>Sala, Ernest</creatorcontrib><creatorcontrib>Cosio, Borja G</creatorcontrib><creatorcontrib>Restrepo, Marcos I</creatorcontrib><creatorcontrib>Anzueto, Antonio</creatorcontrib><creatorcontrib>Chalmers, James D</creatorcontrib><creatorcontrib>Plaza, Vicente</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the American Thoracic Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sibila, Oriol</au><au>Garcia-Bellmunt, Laia</au><au>Giner, Jordi</au><au>Rodrigo-Troyano, Ana</au><au>Suarez-Cuartin, Guillermo</au><au>Torrego, Alfons</au><au>Castillo, Diego</au><au>Solanes, Ingrid</au><au>Mateus, Eder F</au><au>Vidal, Silvia</au><au>Sanchez-Reus, Ferran</au><au>Sala, Ernest</au><au>Cosio, Borja G</au><au>Restrepo, Marcos I</au><au>Anzueto, Antonio</au><au>Chalmers, James D</au><au>Plaza, Vicente</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization</atitle><jtitle>Annals of the American Thoracic Society</jtitle><addtitle>Ann Am Thorac Soc</addtitle><date>2016-05</date><risdate>2016</risdate><volume>13</volume><issue>5</issue><spage>636</spage><epage>642</epage><pages>636-642</pages><issn>2329-6933</issn><eissn>2325-6621</eissn><abstract>Mucins are essential for airway defense against bacteria. We hypothesized that abnormal secreted airway mucin levels would be associated with bacterial colonization in patients with severe chronic obstructive pulmonary disease (COPD) Objectives: To investigate the relationship between mucin levels and the presence of potentially pathogenic micro-organisms in the airways of stable patients with severe COPD Methods: Clinically stable patients with severe COPD were examined prospectively. All patients underwent a computerized tomography scan, lung function tests, induced sputum collection, and bronchoscopy with bronchoalveolar lavage (BAL) and protected specimen brush. Patients with bronchiectasis were excluded. Secreted mucins (MUC2, MUC5AC, and MUC5B) and inflammatory markers were assessed in BAL and sputum by ELISA.
We enrolled 45 patients, with mean age (±SD) of 67 (±8) years and mean FEV1 of 41 (±10) % predicted. A total of 31% (n = 14) of patients had potentially pathogenic micro-organisms in quantitative bacterial cultures of samples obtained by protected specimen brush. Patients with COPD with positive cultures had lower levels of MUC2 both in BAL (P = 0.02) and in sputum (P = 0.01). No differences in MUC5B or MUC5AC levels were observed among the groups. Lower MUC2 levels were correlated with lower FEV1 (r = 0.32, P = 0.04) and higher sputum IL-6 (r = -0.40, P = 0.01).
Airway MUC2 levels are decreased in patients with severe COPD colonized by potentially pathogenic micro-organisms. These findings may indicate one of the mechanisms underlying airway colonization in patients with severe COPD. Clinical trial registered with www.clinicaltrials.gov (NCT01976117).</abstract><cop>United States</cop><pub>American Thoracic Society</pub><pmid>26882402</pmid><doi>10.1513/AnnalsATS.201512-797OC</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2329-6933 |
ispartof | Annals of the American Thoracic Society, 2016-05, Vol.13 (5), p.636-642 |
issn | 2329-6933 2325-6621 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6137898 |
source | MEDLINE; American Thoracic Society (ATS) Journals Online; Alma/SFX Local Collection; Journals@Ovid Complete |
subjects | Aged Biomarkers - analysis Bronchoalveolar Lavage Fluid - microbiology Bronchoscopy Cross-Sectional Studies Female Humans Interleukin-6 - analysis Linear Models Lung - microbiology Lung - physiopathology Male Middle Aged Mucin-2 - analysis Original Research Prospective Studies Pulmonary Disease, Chronic Obstructive - microbiology Pulmonary Disease, Chronic Obstructive - physiopathology Spain Sputum - microbiology Vital Capacity |
title | Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A44%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Airway%20Mucin%202%20Is%20Decreased%20in%20Patients%20with%20Severe%20Chronic%20Obstructive%20Pulmonary%20Disease%20with%20Bacterial%20Colonization&rft.jtitle=Annals%20of%20the%20American%20Thoracic%20Society&rft.au=Sibila,%20Oriol&rft.date=2016-05&rft.volume=13&rft.issue=5&rft.spage=636&rft.epage=642&rft.pages=636-642&rft.issn=2329-6933&rft.eissn=2325-6621&rft_id=info:doi/10.1513/AnnalsATS.201512-797OC&rft_dat=%3Cproquest_pubme%3E1787476722%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1789539930&rft_id=info:pmid/26882402&rfr_iscdi=true |